Nuveen
HUMA icon

Nuveen’s Humacyte HUMA Stock Holding History

Nuveen’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.87K Sell
11,370
-338,065
-97% -$313K ﹤0.01% 3731
2026
Q1 		$212K Buy
349,435
+87,946
+34% +$91.4K ﹤0.01% 3082
2025
Q4 		$251K Hold
261,489
– – ﹤0.01% 3093
2025
Q3 		$455K Hold
261,489
– – ﹤0.01% 2930
2025
Q2 		$547K Sell
261,489
-32,903
-11% -$63.2K ﹤0.01% 2860
2025
Q1 		$502K Hold
294,392
– – ﹤0.01% 2904
2024
Q4 		$1.49M Sell
294,392
-100,748
-25% -$499K ﹤0.01% 2511
2024
Q3 		$2.15M Sell
395,140
-848,538
-68% -$5.59M ﹤0.01% 2380
2024
Q2 		$5.97M Buy
1,243,678
+1,161,900
+1,421% +$6.05M ﹤0.01% 1860
2024
Q1 		$254K Hold
81,778
– – ﹤0.01% 3131
2023
Q4 		$232K Hold
81,778
– – ﹤0.01% 3195
2023
Q3 		$240K Hold
81,778
– – ﹤0.01% 3009
2023
Q2 		$234K Hold
81,778
– – ﹤0.01% 3056
2023
Q1 		$253K Sell
81,778
-64,896
-44% -$185K ﹤0.01% 2944
2022
Q4 		$309K Buy
146,674
+60,828
+71% +$185K ﹤0.01% 2979
2022
Q3 		$280K Sell
85,846
-3,766
-4% -$14.4K ﹤0.01% 3059
2022
Q2 		$288K Buy
89,612
+29,025
+48% +$161K ﹤0.01% 3105
2022
Q1 		$382K Buy
+60,587
New +$353K ﹤0.01% 3075

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nuveen's HUMA Position: Q2 2026 in Review

Nuveen reduced its Humacyte (HUMA) stake by 97% in Q2 2026, selling an estimated $313K and leaving 11,370 shares worth $8.87K. The position accounts for ﹤0.01% of the portfolio, ranked #3731.

Nuveen first reported a position in HUMA in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.97M in Q2 2024. 162 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Nuveen held 11,370 shares of Humacyte worth $8.87K as of Q2 2026.
  • Nuveen sold 338,065 Humacyte shares in Q2 2026, an estimated $313K.
  • Humacyte made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3731 holding.
  • Nuveen first reported a position in Humacyte in Q1 2022 and has held it in 18 quarters since.
  • Nuveen's Humacyte position peaked at $5.97M in Q2 2024.
  • 162 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.